14
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12253 |
Nrf2-IN-1
|
Others; Nrf2 | Immunology/Inflammation; Others |
Nrf2-IN-1 是 Nrf2抑制剂,可用于研究急性髓性白血病药物。 | |||
T11752 |
Keap1-Nrf2-IN-1
Keap1–Nrf2-IN-1 |
Src | Angiogenesis; Tyrosine Kinase/Adaptors |
Keap1–Nrf2 IN-1 activates Nrf2-regulated cytoprotective response and antagonizes acetaminophen-induced liver injury both in cellular and in vivo models. Keap1–Nrf2 IN-1 is a Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 ( | |||
T39514 |
Keap1-Nrf2-IN-3
Keap1-Nrf2-IN-3 |
||
Keap1-Nrf2-IN-3 is a KEAP1:NRF2 protein protein interaction inhibitor, and with a K d value of 2.5 nM for KEAP1 protein. | |||
T64218 | Keap1-Nrf2-IN-1 TFA | ||
Keap1-Nrf2-IN-1 TFA (compound35) 是一种 Keap1-Nrf2 蛋白-蛋白相互作用抑制剂 (IC50: 43 nM),可以激活 Nrf2 调节的细胞保护反应。在细胞和体内模型中。Keap1-Nrf2-IN-1 TFA 能够拮抗对乙酰氨基酚诱导的肝损伤。 | |||
T78841 |
Nrf2-IN-3
|
||
Nrf2-IN-3 (Compound R16) 为Nrf2抑制剂,与KEAP1突变体 (G333C mKEAP1) 结合,能够恢复受损的KEAP1/NRF2相互作用。该化合物通过修复mKEAP1/NRF2复合物,增加KEAP1突变癌细胞对Cisplatin和Gefitinib的敏感性。 | |||
T81984 |
Keap1-Nrf2-IN-10
|
||
Keap1-Nrf2-IN-10(compound 15)作为NQO1诱导剂展现出高效性。该化合物能够在γ辐照小鼠中抑制氧化应激,具体机制是通过降低肝脏MDA、ROS及NQO1水平。此外,Keap1-Nrf2-IN-10能显著提升受γ射线照射小鼠的生存率。 | |||
T79698 |
S217879
|
||
S217879是一种选择性高效的NRF2激活剂,能够破坏KEAP1-NRF2之间的相互作用,从而强有力地激活NRF2通路。它可应用于非酒精性脂肪性肝炎(NASH)的研究领域。 | |||
T74600 |
Keap1-Nrf2-IN-9
|
||
Keap1-Nrf2-IN-9(compound 11)是一种有效Keap1-Nrf2PPI抑制剂,IC50为0.575 µM。该化合物能够提升Nrf2靶基因表达,涉及血红素加氧酶1 (Hmox1)、谷胱甘肽S转移酶P (GstP) 以及谷氨酸-半胱氨酸连接酶的催化(Gclc)与调节(Gclm)亚基。在ARPE19细胞中,Keap1-Nrf2-IN-9展现出无细胞毒活性。 | |||
TP2109 |
TAT 14
|
Nrf2 | Immunology/Inflammation |
TAT-14 是 由14 个氨基酸组成的多肽,是 Nrf2激活因子,表现出抗炎活性。它通过靶向 Nrf2 上 Keap1 的结合位点而非 Nrf2 mRNA 表达来提高 Nrf2 蛋白水平。 | |||
T78697 | Keap1-Nrf2-IN-15 | ||
Keap1-Nrf2-IN-15 (Compound 24a) 作为Keap1-Nrf2蛋白-蛋白相互作用抑制剂,其FP试验与TR-FRET试验的IC50值分别为77 nM和2.5 nM,显示出高效的抑制活性。 | |||
T72687 | Keap1-Nrf2-IN-11 | ||
Keap1-Nrf2-IN-11为Keap1-Nrf2抑制剂,KD2值达0.21 nM。该化合物可有效抑制ROS及NO的生成,并降低TNF-α的表达。通过促进Nrf2的核内转移,Keap1-Nrf2-IN-11对炎症具有调节作用,适用于抗炎研究。 | |||
T61688 | Nrf2 activator-2 | ||
Nrf2 activator-2 (referred to as compound O15), an Osthole derivative, is a highly potent Nrf2 agonist exhibiting an EC 50 of 2.9 μM in 293 T cells. By effectively disrupting the binding between Keap1 and Nrf2, Nrf2 activator-2 activates the Nrf2 pathway. Furthermore, this compound significantly reduces the ubiquitination of Nrf2 in cells, indicating its potential in regulating Nrf2 activity [1]. | |||
T61773 | Keap1-Nrf2-IN-4 | ||
Keap1-Nrf2-IN-4, a powerful neddylation inhibitor, demonstrates significant anti-proliferation activity against MGC-803 cells (IC50 = 2.55 μM), effectively impeding their migration and inducing apoptosis. Additionally, it effectively inhibits tumor growth while exhibiting minimal toxicity [1]. | |||
T64214 |
NXPZ-2
|
||
NXPZ-2 是一种口服具有活力的 Keap1-Nrf2protein–protein interaction(PPI) 抑制剂 (Ki: 95 nM, EC50: 120 and 170 nM)。NXPZ-2 能够上调Nrf2含量,并促进其从细胞质向细胞核的易位,表现出对氧化应激的抑制作用。NXPZ-2 能够剂量依赖性地缓解 Aβ[1-42]诱导的认知紊乱,能够提高神经元数量和功能,增强阿尔茨海默病 (AD) 小鼠脑组织的病理改变情况。NXPZ-2 具有潜力进行 Keap1-Nrf2 PPI 抑制剂和 AD 相关的疾病的研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5171 |
Tricetin
|
Apoptosis; Others; Nrf2 | Apoptosis; Immunology/Inflammation; Others |
Tricetin 是一种从石榴中分离出的类黄酮。Tricetin 是 Keap1-Nrf2 蛋白相互作用(PPI)的强效竞争性抑制剂,通过激活 Nrf2/HO-1 信号通路和阻止线粒体依赖性细胞凋亡通路,保护帕金森病患免受 6-OHDA 诱导的神经毒性的影响。Tricetin 通过 Akt/GSK-1β途径抑制鼻咽癌的迁移和指示性蛋白酶早老素-1(PS-1)表达。Tricetin 抑制由Egr-1介导的氧化LDL 诱导的内皮炎症,保护大鼠软骨细胞免受IL-1β诱导的炎症和细胞凋亡。 | |||
T6S0525 |
Farrerol
|
ERK; p38 MAPK; Akt | Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling |
Farrerol 是一种杜鹃花的生物活性成分,具有抗氧化、抗肿瘤、抗炎、神经保护和肝保护等多种功能。 | |||
T75485 | Dehydrobruceine B | ||
Dehydrobruceine B 是一种苦木素,可从鸦胆子 (Brucea javanica) 中分离得到。Dehydrobruceine B 与 Cisplatin 通过线粒体途径,协同诱导细胞凋亡 (apoptosis)。Dehydrobruceine B 还增加凋亡诱导因子 (AIF) 和 Bax 表达,抑制 Keap1-Nrf2。 | |||
TN3806 |
Dehydroglyasperin C
|
ERK; IκB/IKK; p38 MAPK; TNF; NF-κB; Akt; COX; PI3K; NADPH; DNA/RNA Synthesis; Nrf2; JNK; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; Cytoskeletal Signaling; DNA Damage/DNA Repair; Immunology/Inflammation; MAPK; Metabolism; Neuroscience; NF-κB; PI3K/Akt/mTOR signaling |
Dehydroglyasperin C is a potent NAD(P)H:oxidoquinone reductase (NQO1) and phase 2 enzyme inducer. Dehydroglyasperin C possesses potent antioxidant, cancer chemopreventive, and neuroprotective activities, it has protective effects against chronic diseases |